Reproducible science and randomized clinical trials

from The Incidental Economist at on September 30, 2014 at 07:40PM Empirical studies provide facts to help guide policy and clinical medicine, or at least they do when the study is done well. Good studies are reproducible, that is, any competent scientist should be able to carry out the same procedures and reproduce my results. But there is a crisis across science […]

How the rise of generic drugs affects pharmaceutical innovation

from The Incidental Economist at on September 30, 2014 at 02:24PM For many years, researchers and industry observers have conjectured that rising generic penetration might have an impact on the rate and direction of pharmaceutical innovation. Using a new combination of data sets, we are able to estimate the effects of rising generic penetration […]

Things that make me go ARGH: Overuse of antibiotics for pharyngitis

from The Incidental Economist at on September 30, 2014 at 01:10PM In JAMA Pediatrics: Pharyngitis is a common reason for pediatric health care visits. While viral infections account for the majority of pharyngitis episodes, group A Streptococcus (GAS) is implicated in approximately 37% of episodes among children. Antimicrobial treatment of GAS pharyngitis can shorten illness duration, […]

Fellowships in Cancer Prevention & Control, Virginia Commenwealth University

from ASHEcon at on September 30, 2014 at 11:45AM The NCI-designated Massey Cancer Center at Virginia Commonwealth University/Medical College of Virginia invites applications for a FELLOWSHIP PROGRAM in the ECONOMICS OF CANCER PREVENTION & CONTROL RESEARCH This 2 year flexible program is NIH funded, offering salaries and start-up funds while preparing Fellows for an […]